FTC pauses challenge to Amgen's $27.8B deal for Horizon Therapeutics

Maneuver suspends agency’s litigation over bid for rare-disease drugmaker and charts a path toward settlement.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...